Author:
Dietrich E. S.,Patz E.,Frank U.,Daschner F. D.
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Microbiology (medical),General Medicine
Reference37 articles.
1. Hughes, W. T., Armstrong, D., Bodey, G. P., Feld, R., Mandell, L., Meyers, J. D., Pizzo, P. A., Schimpff, S. C., Shenep, J. L., Wade, J. D., Young, L. S., Yow, M.D. from the Infectious Diseases Society of America: Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. J. Infect. Dis. 161 (1990) 381–396.
2. 1997 Drug Topics Red Book. Medical Economics Company, Inc., Montvale, 1997.
3. Herbrecht, R., Blaise, D., Espinouse, D., Leblond, V., Sadoun, A., Sauvage, C., Cordonnier, C., Minozzi, C.: Isepamicin once daily plus ceftriaxone versus amikacin plus ceftriaxone in febrile neutropenic patients. J. Chemother. 7 (Suppl. 2) (1995) 103–110.
4. Liu, C. Y., Wang, F. D.: A comparative study of ceftriaxone plus amikacin, ceftazidime plus amikacin and imipenem/cilastatin in the empiric therapy of febrile granulocytopenic cancer patients. Chemotherapy 35 (Suppl. 2) (1989) 16–22.
5. Yataganas, X., Rombos, Y., Vayopoulos, G., Meletis, J., Avlami, A.: Randomized clinical trial comparing ceftriaxone/amikacin versus ceftazidime/amikacin as initial therapy of febrile episodes in neutropenic patients. Chemotherapy 37 (1991) 376–381.
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献